IONS FY 2025 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$13B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$944M+33.9% YoY

Gross Profit

$928M98.3% margin

Operating Income

-$382M-40.5% margin

Net Income

-$381M-40.4% margin

EPS (Diluted)

$-2.38

Cash Flow

Operating Cash Flow

-$269M

Free Cash Flow

-$320M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.5B

Total Liabilities

$3.0B

Stockholders' Equity

$489M

Cash & Equivalents

$372M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$944M	$705M	+33.9%
Gross Profit	$928M	$694M	+33.7%
Operating Income	-$382M	-$475M	+19.6%
Net Income	-$381M	-$454M	+16.1%